6022 POSTER Plasma Levels of Heparanase as Marker of Tumour Aggressiveness and Stage of Disease in Patients With Colorectal Cancer

2011 ◽  
Vol 47 ◽  
pp. S398
Author(s):  
E. Dudnik ◽  
A. Kuten
2001 ◽  
Vol 120 (5) ◽  
pp. A599-A600 ◽  
Author(s):  
L HERSZENYI ◽  
F FARINATI ◽  
G ISTVAN ◽  
M PAOLI ◽  
G ROVERONI ◽  
...  

2021 ◽  
Vol 32 ◽  
pp. S1356-S1357
Author(s):  
M. Radanova ◽  
G. Mihaylova ◽  
O. Tasinov ◽  
D. Ivanova ◽  
N. Nazifova-Tasinova ◽  
...  

Metabolites ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. 91 ◽  
Author(s):  
Paul Wood ◽  
Michelle Donohue ◽  
John Cebak ◽  
Taylor Beckmann ◽  
Márcia Messias ◽  
...  

Background: There are currently no blood-based biomarkers for early diagnosis of colorectal cancer. Previous research has suggested that very-long-chain dicarboxylic acid (VLCDCA) 28:4 might be such a biomarker. Methods: Using high-resolution mass spectrometry, we analyzed VLCDCA 28:4 in the plasma of colorectal cancer patients in Italian [n = 62] and Brazilian [n = 52] cohorts. Additionally, we investigated individuals diagnosed with familial adenomatous polyposis (FAP; n = 27), one of the most important clinical forms of inherited susceptibility to colorectal cancer. Results: Decrements in plasma levels of VLCDCA 28:4 were monitored in colorectal cancer patients. These decreases were independent of the stage of tumor development and the individual’s age. However, no decrements in VLCDCA 28:4 were monitored in FAP patients. Conclusions: The plasma levels of VLCDCA 28:4 represent a potential biomarker of sporadic colorectal cancer. In addition, it is possible that resupply of this anti-inflammatory lipid may represent a new therapeutic strategy for CRC and inflammatory disorders.


2003 ◽  
Vol 11 (2) ◽  
pp. 65-70 ◽  
Author(s):  
Attila Fenyvesi

BACKGROUND: Breakdown of basement membrane is believed to be an essential step for tumor invasion and metastasis. The interaction between tumor cells and extracellular matrix can also result in induction of basement membrane synthesis by tumor and stromal cells. The aim of this study was to investigate distribution patterns of type IV collagen expression at the basement membrane in the tumor tissue of colorectal carcinomas by immunohistochemical staining. The degree of expression of type IV collagen correlated with classical clinicopathologic prognostic factors and their potential relationship with patients' prognosis. PATIENTS AND METHODS: This study included 40 patients who underwent curative resection of colorectal cancer at the Department of Surgery in the General Hospital Senta with complete follow-up for 5 years or until death. The identification of basement membrane was performed immunohistochemically using monoclonal antibodies to collagen IV. The basement membrane synthesis at the invasive front of colorectal cancer was semiquantitatively assessed as mild, moderate or severe. RESULTS: The deposition of basement membrane type of collagen IV had a statistically significant correlation with the stage of disease and histological grade of tumor with tendency of lesser synthesis of basement membrane in the advanced stage of disease and poorer histological grade of tumor. There were no significant correlations between intratumoral basement membrane synthesis and sex and age of patients, and localization and histological type of tumor. Five-year survival rates in patients with mild synthesis of basement membrane in colorectal tumor were significantly lower than in patients with severe expression of basement membrane. The basement membrane synthesis in colorectal cancer was a prognostic factor with significance behind stage of disease and histological grade of tumor by univariate Cox hazard-model. Multivariate Cox analysis verified that explicit synthesis of basement membrane showed a trend toward better prognosis, but it was not statistically significant. CONCLUSION Immunohistochemical staining for type IV collagen is an important additional technique with prognostic value.


2018 ◽  
Vol 154 (6) ◽  
pp. S-1314
Author(s):  
H M C Shantha Kumara ◽  
Sandhu K. Jaspreet ◽  
Carl Winkler ◽  
Simon Tian ◽  
Abhinit Shah ◽  
...  

Peptides ◽  
2019 ◽  
Vol 122 ◽  
pp. 170148 ◽  
Author(s):  
Aneta Lidia Zygulska ◽  
Agata Furgala ◽  
Jolanta Kaszuba-Zwoińska ◽  
Krzysztof Krzemieniecki ◽  
Krzysztof Gil

2012 ◽  
Vol 160 (5) ◽  
pp. 709-710 ◽  
Author(s):  
Caterina Musolino ◽  
Alessandro Allegra ◽  
Mirella Profita ◽  
Andrea Alonci ◽  
Salvatore Saitta ◽  
...  

2019 ◽  
Vol 10 (6) ◽  
pp. S110
Author(s):  
J.T. Sales ◽  
L.C. Torres ◽  
M.G. Mello ◽  
E.A. Fonte ◽  
G.L. De Almeida ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document